CBD could decrease anxiety and improve well-being and sleep quality. This has been proven by a recent study that took place in real life.
- According to the Constitutional Council, CBD is not considered a narcotic because it is not characterized by a risk of addiction and harmful effects on health.
- It’s proven: CBD would reduce anxiety, sleep better and improve well-being.
Analgesics, antioxidants, anti-inflammatories… Cannabidiol would contain many properties. “Despite the massive and growing size of the market, there is still little data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed, and scale limitations of the current approach to scientific research” , said Jeff Chen, co-founder and CEO of Radicle Science, a pharmaceutical and academic research model, in a statement. This is why he decided with his team to carry out a study, called “ACES (Advancing CBD Education and Science)”, in order to show the effects of cannabidiol on anxiety and sleep.
This work, which took place in real life for four weeks, relied on a virtual approach. They were conducted among 2,704 people aged 21 or over. Participants suffered from anxiety, chronic pain and sleep disturbances. The volunteers were divided into 14 groups. According to data published by the site Medscape13 groups of 208 adults benefited from one of the 13 oral CBD extracts available on the market and the last group was a control group consisting of 296 people.
CBD would have a real impact on well-being, anxiety and sleep
According to the research, the outcome measure focused on changes “clinically significant”, defined as “distinct and palpable improvements in quality of life”. The preliminary results of the study are promising. And for good reason, participants reported a 71% improvement in their well-being. Additionally, 63% of volunteers reported feeling a reduction in their anxiety and 61% saw their sleep improve. “CBD products provided less benefit in pain management, with less than half (47%) seeing significant improvements”can we read on the site of Medscape.
“It is becoming almost impossible to study cannabinoid compounds, even in randomized controlled trials, due to the multiplication of placebo responses. Combined with the fact that consumers have the mistaken notion that drugs cannabis are miraculous, the expectations are so high that everyone thinks it’s the real stuff, even though it’s a placebo group,” explained Ethan Russo, co-author of the study and scientific expert for Radicle Science.
.
